HOBSCOTCH Phase III
1 other identifier
interventional
140
1 country
1
Brief Summary
The purpose of this study is to determine the efficacy of an entirely virtual version of the home-based cognitive self-management program "HOBSCOTCH." It will test whether HOBSCOTCH can be delivered nationally from a distance utilizing e-health tools (telephone, computer, and phone).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2020
CompletedFirst Posted
Study publicly available on registry
August 20, 2020
CompletedStudy Start
First participant enrolled
November 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 19, 2024
CompletedJuly 1, 2025
June 1, 2025
3.9 years
August 17, 2020
June 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in quality of life
The researchers will use the Quality of Life in Epilepsy (QOLIE-31). This validated tool contains 16 multi-item scales which assess health related quality of life, emotional well-being, memory and attention deficits, medication effects, seizure control, psychosocial functioning, and health perception. Scores range from 0 to 100, with a higher score reflecting a higher quality of life.
Baseline and at months 3, 6, 9, 12
Change in cognitive function
The researchers will use the Cognitive Function sub-scale of the NeuroQOL. This is a brief validated tool developed by the NIH for use in patients with neurological disease. Scores range from 8 to 40, with a higher score indicating better reported cognitive functioning.
Baseline and at months 3, 6, 9, 12
Secondary Outcomes (7)
Change in depression
Baseline and at months 3, 6, 9, 12
Change in self-management practices
Baseline and at months 3, 6, 9, 12
Changes in self-reported seizure frequency
Ongoing through entire study baseline - 12 months
Changes in medication adherence
Ongoing through entire study baseline - 12 months, and at baseline and at months 3, 6, 9, 12
Changes in health confidence
Baseline and at months 3, 6, 9, 12
- +2 more secondary outcomes
Study Arms (2)
HOBSCOTCH-V (virtual)
EXPERIMENTALParticipants will receive the HOBSCOTCH intervention consisting of 1:1 sessions delivered once per week, including: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 6 telephone sessions * 1 wrap-up session (webcam or telephone) Participants will also receive 3 booster sessions, via webcam or telephone, once per month.
Control
OTHERParticipants will be wait listed and will receive HOBSCOTCH-V (above) following a 6 month wait period.
Interventions
HOBSCOTCH is a home-based self-management program to treat cognitive symptoms and improve quality of life, while minimizing the barriers of access to care. The program is based on Problem Solving Therapy (PST) and teaches problem solving strategies and compensatory mechanisms to help manage cognitive dysfunction and enhance quality of life.
Eligibility Criteria
You may qualify if:
- Age 18+
- Diagnosis of epilepsy, with controlled or uncontrolled seizures
- Subjective memory complaints
- No changes in antiepileptic and antidepressant medication regimen for 1 month, however brief discontinuation of antiepileptic medicine for inpatient video EEG evaluation is acceptable
- Literate
- Telephone access
- Internet access
You may not qualify if:
- Subjects self-reporting a dementing illness or a mention of a dementing illness in their medical record
- Severe mental disability or estimated IQ less than 70 per clinical judgement
- Significant visual impairment precluding reading or writing
- No reliable telephone or internet access
- No diagnosis of epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
Related Publications (2)
Caller TA, Secore KL, Ferguson RJ, Roth RM, Alexandre FP, Henegan PL, Harrington JJ, Jobst BC. Design and feasibility of a memory intervention with focus on self-management for cognitive impairment in epilepsy. Epilepsy Behav. 2015 Mar;44:192-4. doi: 10.1016/j.yebeh.2014.12.036. Epub 2015 Feb 27.
PMID: 25731132BACKGROUNDCaller TA, Ferguson RJ, Roth RM, Secore KL, Alexandre FP, Zhao W, Tosteson TD, Henegan PL, Birney K, Jobst BC. A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy. Epilepsy Behav. 2016 Apr;57(Pt A):111-117. doi: 10.1016/j.yebeh.2016.01.024. Epub 2016 Mar 2.
PMID: 26943948BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Jobst, MD
Dartmouth-Hitchcock Medical Center and Dartmouth College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Physician, Neurology
Study Record Dates
First Submitted
August 17, 2020
First Posted
August 20, 2020
Study Start
November 12, 2020
Primary Completion
September 26, 2024
Study Completion
November 19, 2024
Last Updated
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share